|
July
5, 2005 |
|
|
|
|
|
IMAGING
• Aetna
Issues New Reimbursement Policy |
|
QUALITY
IMPROVEMENT
• AMA
Adopts Pay-for-Performance Guidelines
|
|
MEDICAL
LIABILITY REFORM
• Connecticut Governor
Signals Willingness to Sign Liability
Law |
LEGISLATIVE/REGULATORY
• Medicare Pay-for-Performance
Bill Unveiled
• House Approves
FY 2006 Labor-HHS Appropriations Billg
• Drug Tracking Bill
Moves Forward
• FDA Panel Rejects
Artificial Heart |
| IMAGING |
|
Aetna
Issues New Reimbursement Policy
As
of June 15, Aetna will reimburse each
of the add-on codes wall motion study
(78478) and ejection fraction (78480
) when billed with a myocardial perfusion
imaging study (78460-78465). Aetna
recently sent an update in its provider
newsletter explaining the new reimbursement
policy.
ACC
has confirmed with Susan Millerick
and Stacie Watson, Aetna’s spokesperson
and Head of Clinical and Reimbursement
Policy Administration, respectively,
that the system change will allow
reconsideration (retroactive reimbursement)
of claims, based on the May 14 implementation
date, for 180 days (six months) from
the date of the initial claim determination
(Aetna’s date) provided that
the claim was submitted within the
timely filing limits, or 60 days for
an appeal if reconsideration
has previously occurred, provided
appeal rights still exist for the
claim. For more information, contact
Mia Thomas of Payer Advocacy at 301-581-3418. |
| QUALITY
IMPROVEMENT |
|
AMA
Adopts Pay-for-Performance Guidelines
The
American Medical Association (AMA)
House of Delegates has adopted comprehensive
guidelines for pay-for-performance
programs. The guidelines
cover quality of care; the patient/physician
relationship; physician participation;
physician data and reporting; and
program rewards. While the AMA has
tried to forge consensus among the
physician community on a core set
of guidelines and principles, a number
of surgical societies concerned about
the Congress’ interest in moving
to a pay-for-performance system as
early as 2008 amended the resolution
so it states that the AMA oppose any
pay-for-performance programs unless
they meet the guidelines and principles.
Some groups, including the ACC and
the American College of Physicians
(ACP), are concerned about the hard
line that effectively has been drawn
by requiring that all the principles
and guidelines be met. “This
is
going to make it very difficult for
the AMA to engage constructively in
influencing what comes out of Medicare,”
said Robert Doherty, senior vice president
of ACP. |
| MEDICAL
LIABILITY REFORM |
Connecticut
Governor Signals Willingness to Sign
Liability Law
Connecticut
Gov. M. Jodi Rell, R, has said she is
“inclined to sign” a bill
adopted by the state legislature that
would require the state insurance department
to approve malpractice insurance premium
rates of
7.5 percent or higher. The measure also
limits attorney fees in malpractice
cases and reduces interest rates on
malpractice settlements paid over time.
|
| LEGISLATIVE/REGULATORY |
|
Medicare
Pay-for-Performance Bill Unveiled
Senate
Finance Committee Chairman Charles
Grassley, R-IA, and the committee’s
ranking Democrat, Senator Max Baucus,
MT, have introduced a bill to encourage
reporting of quality data. The legislation
would allow the secretary of the Department
of Health and Human Services (HHS)
to first reward providers when they
report quality data and then, again,
when they achieve quality improvements.
The
bill would also authorize a national
healthcare information technology
pilot program. The ACC is currently
reviewing the legislation. |
House
Approves FY 2006 Labor-HHS Appropriations
Bill
The
House of Representatives voted 250-151
to pass the $602 billion Labor-Health
and Human Services-Education appropriations
bill for fiscal year 2006. The measure,
adopted June 24, funds the Medicare
and Medicaid programs and includes monies
to implement the new Medicare prescription
drug program. Funding for the National
Institutes of Health is slated at $28.5
billion, a half-percent increase from
the current year. Prior to passage,
the House rejected an amendment that
would have prohibited the use of appropriated
funds for the distribution of personal
Medicare and Medicaid beneficiary information
to private companies for marketing purposes.
A Senate subcommittee
will take up its version of the funding
measure after the July 4 congressional
recess. |
Drug
Tracking Bill Moves Forward
The
House Energy and Commerce Subcommittee
on Health has marked up legislation
(H.R. 1132) to provide grants to states
to establish a uniform electronic database
system to enable physicians and pharmacists
to flag drug interactions. The measure
would also allow providers to track
patients who abuse prescription drugs.
The Senate Health,
Education, Labor and Pensions Committee
has approved similar legislation. |
FDA
Panel Rejects Artificial Heart
A
Food and Drug Administration (FDA) advisory
panel has recommended, 7-6, that the
agency reject a request by Abiomed to
sell the AbioCor artificial
heart. The panel found that most recipients
of the fully implantable artificial
heart had suffered serious side effects.
|
| Questions?
Comments? Send your feedback to epubs@acc.org
and include the name of the publication
in the subject line. |